Assessment of Group 1 PAH patients on triple therapy clinical four risk strata outcome in a UAE centre - Vienna 2024

Management of patients with pulmonary vascular diseases

Chair(s): David Kiely, Sarah Cullivan

Session type: Poster session

Assessment of Group 1 PAH patients on triple therapy clinical four risk strata outcome in a UAE centre

Khaled Saleh

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Burden and Unmet Needs in Women with Pulmonary Arterial Hypertension: Multinational Physician Qualitative Study

Marion Delcroix

Poster

Abstract

Supplemental oxygen on exercise performance in highlanders with pulmonary vascular disease. A pragmatic open-label crossover RCT

Michael Furian

Poster

Abstract

Real-world treatment patterns and all-cause mortality of pulmonary arterial hypertension in Europe

Katia Mc Verhamme

Poster

Abstract

Assessment of Group 1 PAH patients on triple therapy clinical four risk strata outcome in a UAE centre

Khaled Saleh

Poster

Abstract

Real-world experience with selexipag in patients with pulmonary arterial hypertension in North America and Europe

Nick Kim

Poster

Abstract

Treatment and mortality in mild SSc-PAH

Hilde Jenssen Bj?rkekj

Poster

Abstract

Quantifying the burden of pulmonary arterial hypertension on patients need for caregivers and caregiver work patterns: Results from a Canadian patient survey

Brandon Budhram

Poster

Abstract

Fluid restriction in patients with pulmonary arterial hypertension and right heart failure

Ekkehard Gr?nig

Poster

Abstract

Effect of treatment with ambrisentan in patients with systemic sclerosis and mild pulmonary arterial hypertension: long-term follow-up data from EDITA study

Satenik Harutyunova

Poster

Abstract

Longterm oxygen therapy in precapillary pulmonary hypertension - the SOPHA study.

Ishan Echampati

Poster

Abstract

Patients with pulmonary arterial hypertension: insights from the INSPECTIO study

Stefano De Santis

Poster

Abstract

Real-world experience of elderly patients with pulmonary arterial hypertension (PAH) initiating selexipag (EXPOSURE/EXTRACT studies)

Sean Gaine

Poster

Abstract

Impact of rehabilitation on physical activity in patients with pulmonary vascular disease

St?phanie Saxer

Poster

Abstract

Acute effects of sildenafil on exercise hemodynamics in patients with pulmonary vascular disease: The HEXA RCT series

Simon Raphael Schneider

Poster

Abstract

Nocturnal cerebral oxygenation in patients with pulmonary hypertension staying at 2500m. RCT.

Simon Raphael Schneider

Poster

Abstract

The acute effect of high-dose supplemental oxygen on hemodynamics assessed by echocardiography in patients with pulmonary vascular disease living in Quito at 2850m.

Julian M?ller

Poster

Abstract

Acute effects of normobaric hypoxia on invasively measured exercise hemodynamics in patients with pulmonary vascular disease. The HEXA-RCT

Mona Lichtblau

Poster

Abstract

Efficacy of macitentan/tadalafil single-tablet combination therapy vs pooled monotherapy in pulmonary arterial hypertension (PAH): A DUE post hoc analysis

Ekkehard Gr?nig

Poster

Abstract

Pathway: Non-interventional study to investigate factors influencing treatment decisions in patients with pulmonary hypertension in routine clinical practice.

Hans Klose

Poster

Abstract

Patient experience with transition between intravenous infusion pumps

Liliana Almeida

Poster

Abstract

CDN Connection Issue

The ERS Congress 2024, Vienna

#{title}